Terms: = Colorectal cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Clinical Outcome
1 results:
1. Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy.
De Dosso S; Nucifora M; Sahnane N; Epistolio S; Riveiro ME; Bertolini V; Bucci E; Boldorini R; Freguia S; Frattini M; Saletti P
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2994-3003. PubMed ID: 32271417
[TBL] [Abstract] [Full Text] [Related]
